Scleroderma renal crisis: A retrospective multicentre study on 91 patients and 427 controls

Rheumatology

Volumn 51, Issue 3, 2012, Pages 460-467

  Guillevin, Loïc ^a   Bérezné, Alice ^a   Seror, Raphaèle ^a   Teixeira, Luis ^a   Pourrat, Jacques ^b   Mahr, Alfred ^a   Hachulla, Eric ^c   Agard, Christian ^d   Cabane, Jean ^e   Vanhille, Philippe ^f   Harle, Jean Robert ^g   Deleveaux, Isabelle ^h   Mouthon, Luc ^a  

^a CarMeN   (France)

^b CHU RANGUEIL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d HÔTEL DIEU   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f CENTRE HOSPITALIER DE VALENCIENNES   (France)

^g HÔPITAL DE LA CONCEPTION   (France)

^h SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Angiotensin converting enzyme inhibitor; Renal crisis; Steroids; Systemic sclerosis

Indexed keywords

PREDNISONE;

ADULT; ARTICLE; CONTROLLED STUDY; DIALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCLERODERMA RENAL CRISIS; SYSTEMIC SCLEROSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ACUTE KIDNEY INJURY; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PREDNISONE; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84857573270     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker271     Document Type: Article

References (22)

1. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360:1989-2003.
2. Steen VD. The many faces of scleroderma. Rheum Dis Clin North Am 2008;34:1-15.
3. Traub YM, Shapiro AP, Rodnan GP et al. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine 1983;62:335-52.
4. Penn H, Howie AJ, Kingdon EJ et al. Scleroderma renal crisis: patient characteristics and long-term outcomes. Q J Med 2007;100:485-94.
5. Steen V, Medsger T. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66: 940-4.
6. Teixeira L, Mouthon L, Mahr A et al. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Ann Rheum Dis 2008;67:110-6.
7. Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin-converting enzyme (ACE) inhibitors. Ann Intern Med 1990;113:352-7.
8. Walker J, Ahern M, Smith M et al. Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment. Intern Med J 2003;33:216-20.
9. Teixeira L, Mahr A, Bé rezné A, Noë l LH, Guillevin L, Mouthon L. Scleroderma renal crisis, still a life-threatening complication. Ann N Y Acad Sci 2007;1108:249-58.
10. Masi A, Rodnan G, Medsger T et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
11. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
12. Guillevin L. Le plan national maladies rares: une opportunite ́ pour les patients. Presse Mé d 2008;37:3-5.
13. Steen VD, Syzd A, Johnson JP, Greenberg A, Medsger TA Jr. Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol 2005;32: 649-55.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
15. Steen V, Mayes M, Merkel P. Assessment of kidney involvement. Clin Exp Rheumatol 2003;21(Suppl. 29): S29-31.
16. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
17. Cox D. Regression models and life tables. J R Stat Soc 1972;34:187-219.
18. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-44.
19. Steen VD, Medsger TA Jr. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 1998;41:1613-9.
20. Steen VD, Medsger TA Jr. Long-term outcomes of scleroderma renal crisis. Ann Intern Med 2000;133:600-3.
21. Denton CP, Black CM. Scleroderma - clinical and pathological advances. Best Pract Res Clin Rheumatol 2004;18: 271-90.
22. Bussone G, Bérezné A, Mouthon L. Complications infectieuses de la sclérodermie systémique. Presse Méd 2009; 38:291-302.